Epithelial-Mesenchymal Transition: A Fundamental Cellular and Microenvironmental Process in Benign and Malignant Prostate Pathologies
Open Access
- 11 February 2024
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 12 (2) , 418
Abstract
Epithelial-mesenchymal transition (EMT) is a crucial and fundamental mechanism in many cellular processes, beginning with embryogenesis via tissue remodulation and wound healing, and plays a vital role in tumorigenesis and metastasis formation. EMT is a complex process that involves many transcription factors and genes that enable the tumor cell to leave the primary location, invade the basement membrane, and send metastasis to other tissues. Moreover, it may help the tumor avoid the immune system and establish radioresistance and chemoresistance. It may also change the normal microenvironment, thus promoting other key factors for tumor survival, such as hypoxia-induced factor-1 (HIF-1) and promoting neoangiogenesis. In this review, we will focus mainly on the role of EMT in benign prostate disease and especially in the process of establishment of malignant prostate tumors, their invasiveness, and aggressive behavior. We will discuss relevant study methods for EMT evaluation and possible clinical implications. We will also introduce clinical trials conducted according to CONSORT 2010 that try to harness EMT properties in the form of circulating tumor cells to predict aggressive patterns of prostate cancer. This review will provide the most up-to-date information to establish a keen understanding of the cellular and microenvironmental processes for developing novel treatment lines by modifying or blocking the pathways.Keywords
Funding Information
- a DRO (00098892, NU20-03-00201)
- Czech Ministry of Health (00098892, NU20-03-00201)
This publication has 129 references indexed in Scilit:
- The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patientsThe Journal of Pathology: Clinical Research, 2021
- The dark-side of the outside: how extracellular heat shock proteins promote cancerCellular and Molecular Life Sciences, 2021
- Kallikrein‐related peptidase 4 induces cancer‐associated fibroblast features in prostate‐derived stromal cellsMolecular Oncology, 2017
- The role of epithelial–mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel‐resistant prostate cancerMolecular Oncology, 2017
- A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) studyInvestigational New Drugs, 2015
- TGF‐β1‐induced EMT of non‐transformed prostate hyperplasia cells is characterized by early induction of SNAI2/SlugThe Prostate, 2011
- Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor ProgressionJournal of Mammary Gland Biology and Neoplasia, 2010
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer CellsStem Cells, 2009
- The role of the ZEB family of transcription factors in development and diseaseCellular and Molecular Life Sciences, 2008
- A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patientsInvestigational New Drugs, 2006